Epstein Index›Documents›EFTA01113072
💨IMPACT LEVEL 1 — MEH

Epstein File EFTA01113072: First Time and Treat (DS9)

Media / PressDate unavailableEFTA011130721 keyword hits
0
views
0
shares
0
reactions
0
persons
2
keywords
2
excerpts

This document contains a business announcement from Che Fengsheng, Chairman and CEO of Sihuan Pharmaceutical, describing a breakthrough in business development as the first time Sihuan Pharmaceutical has achieved a particular milestone. The excerpt also references NeuroVive Pharmaceutical AB and its development of mitochondrial medicine products.

👤 Named in This Document
No named persons linked yet
🔑 Evidence Keywords

📋 Key Excerpts2

PersonKeyword
Excerpt 1
Che Fengsheng, Chairman and CEO of Sihuan Pharmaceutical, said: "This is a breakthrough for our business development as it is the **first** **time** Sihuan Pharmaceutical
Excerpt 2
Pharmaceutical AB NeuroVive Pharmaceutical AB (www.neurovive.com) the leading mitochondrial medicine company is developing a portfolio of products to **treat**

Discussion

Let the world know how you feel.

What you just read should make you angry. Channel that into 17 syllables. Our AI helps you craft a haiku in seconds — then share it with the world.

Power hides in dark But sunlight finds every crack Truth cannot be bought

— Sarah K., after reading this document
✍️ Write Your Haiku

Haikus for Humanity — 5 · 7 · 5

React
Share𝕏🦋FBinFund Accountability